The FDA will continue recommending annual COVID-19 vaccines for older adults and high-risk groups, but says more clinical data is needed for healthy adults and kids.

"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...

The best approach to covid-19 prevention may be to discuss it with your doctor, a leading vaccine expert told TribLive. But a drastic shift in national policy published Tuesday in the New England ...

Photo: Adobe Stock The Food and Drug Administration (FDA) published new Evidence-Based guidelines for COVID-19 vaccination ...

US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

The FDA is getting rid of the Covid booster because . . . it's concerned about anti-vaxx sentiments. No, really.

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.